A rare TNNT1 gene variant causing creatine kinase elevation in nemaline myopathy: c.271_273del (p.Lys91del)
| dc.authorid | 0000-0002-1597-5922 | |
| dc.contributor.author | Yavaş, Cüneyd | |
| dc.contributor.author | Doğan, Mustafa | |
| dc.contributor.author | Eröz, Recep | |
| dc.contributor.author | Türegün, Kübra | |
| dc.date.accessioned | 2024-07-04T06:21:41Z | |
| dc.date.available | 2024-07-04T06:21:41Z | |
| dc.date.issued | 2024 | |
| dc.department | Tıp Fakültesi | |
| dc.description.abstract | Nemaline Myopathy (NM) is a rare genetic disorder that affects muscle function and is characterized by the presence of nemaline rods in muscle fibers. These rods are abnormal structures that interfere with muscle contraction and can cause muscle weakness, respiratory distress, and other complications. NM is caused by variants in several genes, including TNNT1, which encodes the protein troponin T1. NM is inherited in an autosomal recessive pattern. The prevalence of heterozygous TNNT1 variants has been reported to be 1/152,000, indicating that the disease is relatively rare. Objective: Investigation of TNNT1 gene variants that may cause cretin kinase elevation. Methods: Detailed family histories and clinical data were recorded. Whole exome sequencing was performed and family segregation was done by Sanger sequencing. Results: In this study, we report a 5-year-old girl with a novel variant recessive congenital TNNT1 myopathy. The patient had a novel homozygous (c.271_273del) deletion in the TNNT1 gene that is associated with creatine kinase elevation, which is a marker of muscle damage. Conclusion: This case expands the phenotypic spectrum of TNNT1 myopathy and highlights the importance of genetic testing and counseling for families affected by this rare disorder. In this study provides valuable insights into the genetic basis of NM and highlights the importance of early diagnosis and management for patients with this rare disorder. Further research is needed to better understand the pathophysiology of TNNT1 myopathy and to develop effective treatments for this debilitating condition. | |
| dc.identifier.doi | 10.1007/s13258-024-01502-0 | |
| dc.identifier.endpage | 620 | en_US |
| dc.identifier.issn | 1976-9571 | |
| dc.identifier.issue | 5 | en_US |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 613 | en_US |
| dc.identifier.uri | https:/dx.doi.org/10.1007/s13258-024-01502-0 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12451/12045 | |
| dc.identifier.volume | 46 | en_US |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Genetics Society of Korea | |
| dc.relation.ispartof | Genes and Genomics | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Amish Nemaline Myopathy | |
| dc.subject | Creatine Kinase | |
| dc.subject | Muscle Loss | |
| dc.subject | TNNT1 | |
| dc.subject | Whole Exome Sequence | |
| dc.title | A rare TNNT1 gene variant causing creatine kinase elevation in nemaline myopathy: c.271_273del (p.Lys91del) | |
| dc.type | Article |
